首页 > 最新文献

Mitochondrion最新文献

英文 中文
Escherichia coli infection induces ferroptosis in bovine mammary epithelial cells by activating the Wnt/β-catenin pathway-mediated mitophagy 大肠埃希氏菌感染通过激活 Wnt/β-catenin 通路介导的有丝分裂,诱导牛乳腺上皮细胞铁变态反应
IF 4.4 3区 生物学 Q2 CELL BIOLOGY Pub Date : 2024-06-15 DOI: 10.1016/j.mito.2024.101921
Cuicui Zhuang , Yang Liu , Herman W. Barkema , Zhaoju Deng , Jian Gao , John P. Kastelic , Bo Han , Jianhai Zhang

Iron overload causes mitochondrial damage, and then activates mitophagy, which may directly trigger and amplify ferroptosis. Our objective was to investigate whether Escherichia coli (E. coli) isolated from clinical bovine mastitis induces ferroptosis in bovine mammary epithelial cells (bMECs) and if so, the underlying regulatory mechanism. E. coli infection caused mitochondrial damage, mitophagy, and ferroptosis. Rapamycin and chloroquine increased and suppressed ferroptosis, respectively, in E. coli-treated bMECs. Moreover, E. coli infection activated the Wnt/β-catenin pathway, but foscenvivint alleviated it. In conclusion, E. coli infection induced ferroptosis through activation of the Wnt/β-catenin pathway-promoted mitophagy, and it also suppressed GPX4 expression.

铁超载会导致线粒体损伤,进而激活有丝分裂,而有丝分裂可能会直接触发和放大铁嗜酸性粒细胞增多症。我们的目的是研究从临床牛乳腺炎中分离出的大肠埃希菌(E. coli)是否会诱导牛乳腺上皮细胞(bMECs)发生铁突变,如果会,其潜在的调控机制是什么。大肠杆菌感染会导致线粒体损伤、丝裂噬和铁蛋白沉积。雷帕霉素和氯喹分别增加和抑制了大肠杆菌处理的 bMECs 的铁突变。此外,大肠杆菌感染激活了Wnt/β-catenin通路,而福斯康定则缓解了这一情况。总之,大肠杆菌感染通过激活 Wnt/β-catenin 通路促进有丝分裂,从而诱导铁变态反应,同时也抑制了 GPX4 的表达。
{"title":"Escherichia coli infection induces ferroptosis in bovine mammary epithelial cells by activating the Wnt/β-catenin pathway-mediated mitophagy","authors":"Cuicui Zhuang ,&nbsp;Yang Liu ,&nbsp;Herman W. Barkema ,&nbsp;Zhaoju Deng ,&nbsp;Jian Gao ,&nbsp;John P. Kastelic ,&nbsp;Bo Han ,&nbsp;Jianhai Zhang","doi":"10.1016/j.mito.2024.101921","DOIUrl":"10.1016/j.mito.2024.101921","url":null,"abstract":"<div><p>Iron overload causes mitochondrial damage, and then activates mitophagy, which may directly trigger and amplify ferroptosis. Our objective was to investigate whether <em>Escherichia coli</em> (<em>E. coli</em>) isolated from clinical bovine mastitis induces ferroptosis in bovine mammary epithelial cells (bMECs) and if so, the underlying regulatory mechanism. <em>E. coli</em> infection caused mitochondrial damage, mitophagy, and ferroptosis. Rapamycin and chloroquine increased and suppressed ferroptosis, respectively, in <em>E. coli</em>-treated bMECs. Moreover, <em>E. coli</em> infection activated the Wnt/β-catenin pathway, but foscenvivint alleviated it. In conclusion, <em>E. coli</em> infection induced ferroptosis through activation of the Wnt/β-catenin pathway-promoted mitophagy, and it also suppressed GPX4 expression.</p></div>","PeriodicalId":18606,"journal":{"name":"Mitochondrion","volume":"78 ","pages":"Article 101921"},"PeriodicalIF":4.4,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141391117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased expression of SLC25A18 is associated with Alzheimer’s disease and is involved in Aβ42-induced mitochondrial dysfunction and apoptosis in neuronal cells SLC25A18 的表达增加与阿尔茨海默病有关,并参与 Aβ42 诱导的线粒体功能障碍和神经细胞凋亡。
IF 4.4 3区 生物学 Q2 CELL BIOLOGY Pub Date : 2024-06-12 DOI: 10.1016/j.mito.2024.101918
Jia-Yi Song , Yong Jia , Hao Han , Xue-Han Yang , Jing Zhang , Qiang Zhang , Su-Shan Wang , Chun-Yan Wang , Li Chen , Ming Zhang

Alzheimer’s disease (AD) is currently one of the most serious public health concerns in the world. However, the best approach to treat AD has yet to be discovered, implying that we must continue to work hard to find new AD target genes. In this study, we further analysed Gene Expression Omnibus (GEO) data and discovered that the expression of the Mitochondria glutamate carrier SLC25A18 is associated with AD by screening the differentially expressed genes in different regions of the brains of Alzheimer’s disease patients. To verify the expression of SLC25A18 during Alzheimer’s disease development, we analysed animal models (5×FAD transgenic AD animal model, chemically induced AD animal model, natural ageing animal model), and the results showed that the expression of SLC25A18 was increased in animal models of AD. Further investigation of the different regions found that SLC25A18 expression was elevated in the EC, TeA, and CA3, and expressed in neurons. Next, We found that Aβ42 treatment elevated SLC25A18 expression in Neuro 2A cells. Reducing SLC25A18 expression attenuated mitochondrial dysfunction and neuronal apoptosis caused by Aβ42. Overexpression of SLC25A18 increased ATP and intracellular superoxide anions but decreased mitochondrial membrane potential. The results indicate that SLC25A18 affects mitochondrial function and neuronal apoptosis, and is related to AD, which makes it a potential target for treating brain dysfunction.

阿尔茨海默病(AD)是目前全球最严重的公共卫生问题之一。然而,治疗阿尔茨海默病的最佳方法尚未发现,这意味着我们必须继续努力寻找新的阿尔茨海默病靶基因。在这项研究中,我们进一步分析了基因表达总库(Gene Expression Omnibus,GEO)数据,通过筛选阿尔茨海默病患者大脑不同区域的差异表达基因,发现线粒体谷氨酸载体SLC25A18的表达与AD有关。为了验证 SLC25A18 在阿尔茨海默病发病过程中的表达情况,我们对动物模型(5×FAD 转基因 AD 动物模型、化学诱导 AD 动物模型、自然衰老动物模型)进行了分析,结果表明 SLC25A18 在 AD 动物模型中的表达增加。对不同区域的进一步研究发现,SLC25A18在EC、TeA和CA3中表达升高,并在神经元中表达。接着,我们发现 Aβ42 处理可提高神经 2A 细胞中 SLC25A18 的表达。降低 SLC25A18 的表达可减轻 Aβ42 导致的线粒体功能障碍和神经元凋亡。过表达 SLC25A18 会增加 ATP 和细胞内超氧化物阴离子,但会降低线粒体膜电位。结果表明,SLC25A18会影响线粒体功能和神经元凋亡,并与AD有关,因此是治疗脑功能障碍的潜在靶点。
{"title":"Increased expression of SLC25A18 is associated with Alzheimer’s disease and is involved in Aβ42-induced mitochondrial dysfunction and apoptosis in neuronal cells","authors":"Jia-Yi Song ,&nbsp;Yong Jia ,&nbsp;Hao Han ,&nbsp;Xue-Han Yang ,&nbsp;Jing Zhang ,&nbsp;Qiang Zhang ,&nbsp;Su-Shan Wang ,&nbsp;Chun-Yan Wang ,&nbsp;Li Chen ,&nbsp;Ming Zhang","doi":"10.1016/j.mito.2024.101918","DOIUrl":"10.1016/j.mito.2024.101918","url":null,"abstract":"<div><p>Alzheimer’s disease (AD) is currently one of the most serious public health concerns in the world. However, the best approach to treat AD has yet to be discovered, implying that we must continue to work hard to find new AD target genes. In this study, we further analysed Gene Expression Omnibus (GEO) data and discovered that the expression of the Mitochondria glutamate carrier SLC25A18 is associated with AD by screening the differentially expressed genes in different regions of the brains of Alzheimer’s disease patients. To verify the expression of SLC25A18 during Alzheimer’s disease development, we analysed animal models (5×FAD transgenic AD animal model, chemically induced AD animal model, natural ageing animal model), and the results showed that the expression of SLC25A18 was increased in animal models of AD. Further investigation of the different regions found that SLC25A18 expression was elevated in the EC, TeA, and CA3, and expressed in neurons. Next, We found that Aβ42 treatment elevated SLC25A18 expression in Neuro 2A cells. Reducing SLC25A18 expression attenuated mitochondrial dysfunction and neuronal apoptosis caused by Aβ42. Overexpression of SLC25A18 increased ATP and intracellular superoxide anions but decreased mitochondrial membrane potential. The results indicate that SLC25A18 affects mitochondrial function and neuronal apoptosis, and is related to AD, which makes it a potential target for treating brain dysfunction.</p></div>","PeriodicalId":18606,"journal":{"name":"Mitochondrion","volume":"78 ","pages":"Article 101918"},"PeriodicalIF":4.4,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S156772492400076X/pdfft?md5=a6d038576477b989162d7b765a2d4446&pid=1-s2.0-S156772492400076X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141317690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The interplay between mitophagy and mitochondrial ROS in acute lung injury 急性肺损伤中有丝分裂与线粒体 ROS 之间的相互作用
IF 3.9 3区 生物学 Q2 CELL BIOLOGY Pub Date : 2024-06-12 DOI: 10.1016/j.mito.2024.101920
Yizhi Zhong , Siwei Xia , Gaojian Wang , Qinxue Liu , Fengjie Ma , Yijin Yu , Yaping Zhang , Lu Qian , Li Hu , Junran Xie

Mitochondria orchestrate the production of new mitochondria and the removal of damaged ones to dynamically maintain mitochondrial homeostasis through constant biogenesis and clearance mechanisms. Mitochondrial quality control particularly relies on mitophagy, defined as selective autophagy with mitochondria-targeting specificity. Most ROS are derived from mitochondria, and the physiological concentration of mitochondrial ROS (mtROS) is no longer considered a useless by-product, as it has been proven to participate in immune and autophagy pathway regulation. However, excessive mtROS appears to be a pathogenic factor in several diseases, including acute lung injury (ALI). The interplay between mitophagy and mtROS is complex and closely related to ALI. Here, we review the pathways of mitophagy, the intricate relationship between mitophagy and mtROS, the role of mtROS in the pathogenesis of ALI, and their effects and related progression in ALI induced by different conditions.

线粒体通过不断的生物生成和清除机制,协调新线粒体的生成和受损线粒体的清除,以动态维持线粒体的平衡。线粒体质量控制尤其依赖于线粒体吞噬,线粒体吞噬被定义为具有线粒体靶向特异性的选择性自噬。大多数 ROS 来自线粒体,线粒体 ROS(mtROS)的生理浓度不再被认为是无用的副产品,因为它已被证明参与免疫和自噬途径的调节。然而,过量的线粒体 ROS 似乎是包括急性肺损伤(ALI)在内的多种疾病的致病因素。有丝分裂与 mtROS 之间的相互作用非常复杂,且与 ALI 密切相关。在此,我们回顾了有丝分裂的途径、有丝分裂与mtROS之间错综复杂的关系、mtROS在ALI发病机制中的作用,以及它们在不同情况下诱发的ALI中的影响和相关进展。
{"title":"The interplay between mitophagy and mitochondrial ROS in acute lung injury","authors":"Yizhi Zhong ,&nbsp;Siwei Xia ,&nbsp;Gaojian Wang ,&nbsp;Qinxue Liu ,&nbsp;Fengjie Ma ,&nbsp;Yijin Yu ,&nbsp;Yaping Zhang ,&nbsp;Lu Qian ,&nbsp;Li Hu ,&nbsp;Junran Xie","doi":"10.1016/j.mito.2024.101920","DOIUrl":"10.1016/j.mito.2024.101920","url":null,"abstract":"<div><p>Mitochondria orchestrate the production of new mitochondria and the removal of damaged ones to dynamically maintain mitochondrial homeostasis through constant biogenesis and clearance mechanisms. Mitochondrial quality control particularly relies on mitophagy, defined as selective autophagy with mitochondria-targeting specificity. Most ROS are derived from mitochondria, and the physiological concentration of mitochondrial ROS (mtROS) is no longer considered a useless by-product, as it has been proven to participate in immune and autophagy pathway regulation. However, excessive mtROS appears to be a pathogenic factor in several diseases, including acute lung injury (ALI). The interplay between mitophagy and mtROS is complex and closely related to ALI. Here, we review the pathways of mitophagy, the intricate relationship between mitophagy and mtROS, the role of mtROS in the pathogenesis of ALI, and their effects and related progression in ALI induced by different conditions.</p></div>","PeriodicalId":18606,"journal":{"name":"Mitochondrion","volume":"78 ","pages":"Article 101920"},"PeriodicalIF":3.9,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141321214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid hormone enhances efficacy of cisplatin in lung cancer patients via down-regulating GLUT1 expression and reversing the Warburg effect 甲状腺激素通过下调 GLUT1 表达和逆转沃伯格效应增强顺铂对肺癌患者的疗效。
IF 3.9 3区 生物学 Q2 CELL BIOLOGY Pub Date : 2024-06-12 DOI: 10.1016/j.mito.2024.101919
Chenchen Fan , Yanbei Ren , Wen Zhang , Jing Wen , Wenjia Zhang , Shumeng Lin , Yidong Bai , Tiansheng Zheng , Baigenzhin Abay , Ming Li , Lihong Fan

Cisplatin (CDDP) is a standard non-small cell lung cancer (NSCLC) chemotherapy, but its efficacy is hampered by resistance, partly due to the Warburg effect. This study investigates how thyroid hormones enhance the Warburg effect, increasing sensitivity to cisplatin in lung cancer. Clinical data from advanced NSCLC patients were analyzed based on thyroid hormone levels, categorizing patients into high and low groups. Cellular experiments involved Control, 10uM CDDP, 10uM CDDP + 0.1uM T3, and 10uM CDDP + 0.1uM T4 categories. Parameters were measured in A549 and PC9 lung cancer cells, including proliferation, apoptosis, mitochondrial membrane potential, ROS production, glycolysis enzyme activity, lactic acid level, and ATP content. Gene and protein expressions were assessed using qPCR and Western Blot. Analysis revealed higher FT3 levels correlated with prolonged progression-free survival before chemotherapy (median PFS: high FT3 group = 12.67 months, low FT3 group = 7.03 months, p = 0.01). Cellular experiments demonstrated that thyroid hormones increase lung cancer cell sensitivity to cisplatin, inhibiting proliferation and enhancing efficacy. The mechanism involves thyroid hormones and cisplatin jointly down-regulating MSI1/AKT/GLUT1 expression, reducing lactic acid and glycolysis. This Warburg effect reversal boosts ATP levels, elevates ROS, and decreases MMP, enhancing cisplatin effectiveness in A549 and PC9 cells. In conclusion, elevated free T3 levels in advanced NSCLC patients correlate with prolonged progression-free survival under cisplatin chemotherapy. Cellular experiments reveal that thyroid hormones enhance lung cancer cell sensitivity to cisplatin by reversing the Warburg effect, providing a mechanistic basis for improved therapeutic outcomes.

顺铂(CDDP)是一种标准的非小细胞肺癌(NSCLC)化疗药物,但其疗效却受到耐药性的影响,部分原因是沃伯格效应。本研究探讨了甲状腺激素如何增强沃伯格效应,从而提高肺癌患者对顺铂的敏感性。根据甲状腺激素水平分析了晚期 NSCLC 患者的临床数据,将患者分为高水平组和低水平组。细胞实验包括对照组、10uM CDDP 组、10uM CDDP + 0.1uM T3 组和 10uM CDDP + 0.1uM T4 组。测量了 A549 和 PC9 肺癌细胞的参数,包括增殖、凋亡、线粒体膜电位、ROS 产生、糖酵解酶活性、乳酸水平和 ATP 含量。基因和蛋白质表达采用 qPCR 和 Western 印迹法进行评估。分析显示,较高的 FT3 水平与化疗前无进展生存期的延长相关(中位 PFS:高 FT3 组 = 12.67 个月,低 FT3 组 = 7.03 个月,P = 0.01)。细胞实验证明,甲状腺激素能增加肺癌细胞对顺铂的敏感性,抑制增殖并提高疗效。其机制是甲状腺激素和顺铂共同下调MSI1/AKT/GLUT1的表达,减少乳酸和糖酵解。这种沃伯格效应逆转提高了 ATP 水平,增加了 ROS,降低了 MMP,从而增强了顺铂在 A549 和 PC9 细胞中的有效性。总之,晚期 NSCLC 患者游离 T3 水平的升高与顺铂化疗无进展生存期的延长相关。细胞实验显示,甲状腺激素通过逆转沃伯格效应提高了肺癌细胞对顺铂的敏感性,为改善治疗效果提供了机理基础。
{"title":"Thyroid hormone enhances efficacy of cisplatin in lung cancer patients via down-regulating GLUT1 expression and reversing the Warburg effect","authors":"Chenchen Fan ,&nbsp;Yanbei Ren ,&nbsp;Wen Zhang ,&nbsp;Jing Wen ,&nbsp;Wenjia Zhang ,&nbsp;Shumeng Lin ,&nbsp;Yidong Bai ,&nbsp;Tiansheng Zheng ,&nbsp;Baigenzhin Abay ,&nbsp;Ming Li ,&nbsp;Lihong Fan","doi":"10.1016/j.mito.2024.101919","DOIUrl":"10.1016/j.mito.2024.101919","url":null,"abstract":"<div><p>Cisplatin (CDDP) is a standard non-small cell lung cancer (NSCLC) chemotherapy, but its efficacy is hampered by resistance, partly due to the Warburg effect. This study investigates how thyroid hormones enhance the Warburg effect, increasing sensitivity to cisplatin in lung cancer. Clinical data from advanced NSCLC patients were analyzed based on thyroid hormone levels, categorizing patients into high and low groups. Cellular experiments involved Control, 10uM CDDP, 10uM CDDP + 0.1uM T3, and 10uM CDDP + 0.1uM T4 categories. Parameters were measured in A549 and PC9 lung cancer cells, including proliferation, apoptosis, mitochondrial membrane potential, ROS production, glycolysis enzyme activity, lactic acid level, and ATP content. Gene and protein expressions were assessed using qPCR and Western Blot. Analysis revealed higher FT3 levels correlated with prolonged progression-free survival before chemotherapy (median PFS: high FT3 group = 12.67 months, low FT3 group = 7.03 months, p = 0.01). Cellular experiments demonstrated that thyroid hormones increase lung cancer cell sensitivity to cisplatin, inhibiting proliferation and enhancing efficacy. The mechanism involves thyroid hormones and cisplatin jointly down-regulating MSI1/AKT/GLUT1 expression, reducing lactic acid and glycolysis. This Warburg effect reversal boosts ATP levels, elevates ROS, and decreases MMP, enhancing cisplatin effectiveness in A549 and PC9 cells. In conclusion, elevated free T3 levels in advanced NSCLC patients correlate with prolonged progression-free survival under cisplatin chemotherapy. Cellular experiments reveal that thyroid hormones enhance lung cancer cell sensitivity to cisplatin by reversing the Warburg effect, providing a mechanistic basis for improved therapeutic outcomes.</p></div>","PeriodicalId":18606,"journal":{"name":"Mitochondrion","volume":"78 ","pages":"Article 101919"},"PeriodicalIF":3.9,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141321215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of mitochondrial genes in ischemia-reperfusion injury: A systematic review of experimental studies 线粒体基因在缺血再灌注损伤中的作用:实验研究的系统回顾。
IF 4.4 3区 生物学 Q2 CELL BIOLOGY Pub Date : 2024-06-06 DOI: 10.1016/j.mito.2024.101908
Zeyu Chen , Daniel Rayner , Robert Morton , Laura Banfield , Guillaume Paré , Michael Chong

Mitochondrial dysfunction contributes to pathological conditions like ischemia–reperfusion (IR) injury. To address the lack of effective therapeutic interventions for IR injury and potential knowledge gaps in the current literature, we systematically reviewed 3800 experimental studies across 5 databases and identified 20 mitochondrial genes impacting IR injury in various organs. Notably, CyPD, Nrf2, and GPX4 are well-studied genes consistently influencing IR injury outcomes. Emerging genes like ALDH2, BNIP3, and OPA1 are supported by human genetic evidence, thereby warranting further investigation. Findings of this review can inform future research directions and inspire therapeutic advancements.

线粒体功能障碍会导致缺血再灌注(IR)损伤等病理状况。为了解决线粒体损伤缺乏有效治疗干预的问题以及现有文献中潜在的知识空白,我们系统地回顾了 5 个数据库中的 3800 项实验研究,并确定了 20 个影响不同器官线粒体损伤的线粒体基因。值得注意的是,CyPD、Nrf2 和 GPX4 是研究较多的基因,一直影响着红外损伤的结果。ALDH2、BNIP3 和 OPA1 等新出现的基因得到了人类遗传学证据的支持,因此值得进一步研究。本综述的研究结果可为未来的研究方向提供参考,并激励治疗方法的进步。
{"title":"The role of mitochondrial genes in ischemia-reperfusion injury: A systematic review of experimental studies","authors":"Zeyu Chen ,&nbsp;Daniel Rayner ,&nbsp;Robert Morton ,&nbsp;Laura Banfield ,&nbsp;Guillaume Paré ,&nbsp;Michael Chong","doi":"10.1016/j.mito.2024.101908","DOIUrl":"10.1016/j.mito.2024.101908","url":null,"abstract":"<div><p>Mitochondrial dysfunction contributes to pathological conditions like ischemia–reperfusion (IR) injury. To address the lack of effective therapeutic interventions for IR injury and potential knowledge gaps in the current literature, we systematically reviewed 3800 experimental studies across 5 databases and identified 20 mitochondrial genes impacting IR injury in various organs. Notably, <em>CyPD, Nrf2,</em> and <em>GPX4</em> are well-studied genes consistently influencing IR injury outcomes. Emerging genes like <em>ALDH2, BNIP3,</em> and <em>OPA1</em> are supported by human genetic evidence, thereby warranting further investigation. Findings of this review can inform future research directions and inspire therapeutic advancements.</p></div>","PeriodicalId":18606,"journal":{"name":"Mitochondrion","volume":"78 ","pages":"Article 101908"},"PeriodicalIF":4.4,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1567724924000667/pdfft?md5=d2423e2c09b93620a942ba7e3ae8febf&pid=1-s2.0-S1567724924000667-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141288320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver mitochondrial coupling efficiency and its relationship to oxidative capacity and adenine nucleotide translocase content: A comparative study among crocodiles, birds and mammals 肝脏线粒体偶联效率及其与氧化能力和腺嘌呤核苷酸转运酶含量的关系:鳄鱼、鸟类和哺乳动物的比较研究。
IF 4.4 3区 生物学 Q2 CELL BIOLOGY Pub Date : 2024-06-04 DOI: 10.1016/j.mito.2024.101909
Damien Roussel , Nathan Roussel , Yann Voituron , Benjamin Rey

The primary objective of this study was to assess whether adenine nucleotide translocase (ANT) content could be associated with phylogenetic disparities in mitochondrial coupling efficiency, within liver mitochondria obtained from rats, crocodiles, and ducklings. Our measurements included mitochondrial membrane conductance, ANT content, and oxidative phosphorylation fluxes at various steady-state rates. We observed significant variations in liver mitochondrial coupling efficiency across the three species. These variations correlated with interspecific differences in mitochondrial oxidative capacity and, to a lesser extent, the ANT content of liver mitochondria. These findings expand upon previous research by highlighting the pivotal role of oxidative capacity and ANT in modulating mitochondrial efficiency on an interspecific scale.

本研究的主要目的是评估腺嘌呤核苷酸转位酶(ANT)含量是否与大鼠、鳄鱼和鸭子肝脏线粒体中线粒体耦合效率的系统发育差异有关。我们的测量包括线粒体膜电导率、ANT含量和各种稳态速率下的氧化磷酸化通量。我们观察到这三个物种的肝脏线粒体耦合效率存在明显差异。这些差异与线粒体氧化能力的种间差异有关,其次与肝脏线粒体的ANT含量有关。这些发现拓展了之前的研究,强调了氧化能力和ANT在调节种间线粒体效率中的关键作用。
{"title":"Liver mitochondrial coupling efficiency and its relationship to oxidative capacity and adenine nucleotide translocase content: A comparative study among crocodiles, birds and mammals","authors":"Damien Roussel ,&nbsp;Nathan Roussel ,&nbsp;Yann Voituron ,&nbsp;Benjamin Rey","doi":"10.1016/j.mito.2024.101909","DOIUrl":"10.1016/j.mito.2024.101909","url":null,"abstract":"<div><p>The primary objective of this study was to assess whether adenine nucleotide translocase (ANT) content could be associated with phylogenetic disparities in mitochondrial coupling efficiency, within liver mitochondria obtained from rats, crocodiles, and ducklings. Our measurements included mitochondrial membrane conductance, ANT content, and oxidative phosphorylation fluxes at various steady-state rates. We observed significant variations in liver mitochondrial coupling efficiency across the three species. These variations correlated with interspecific differences in mitochondrial oxidative capacity and, to a lesser extent, the ANT content of liver mitochondria. These findings expand upon previous research by highlighting the pivotal role of oxidative capacity and ANT in modulating mitochondrial efficiency on an interspecific scale.</p></div>","PeriodicalId":18606,"journal":{"name":"Mitochondrion","volume":"78 ","pages":"Article 101909"},"PeriodicalIF":4.4,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141284232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways 细胞穿透肽与纳米颗粒混合输送载体及其吸收途径
IF 4.4 3区 生物学 Q2 CELL BIOLOGY Pub Date : 2024-05-24 DOI: 10.1016/j.mito.2024.101906
Moataz Dowaidar

Cell-penetrating peptides (CPPs) are molecules that improve the cellular uptake of various molecular payloads that do not easily traverse the cellular membrane. CPPs can be found in pharmaceutical and medical products. The vast majority of cell-penetrating chemicals that are discussed in published research are peptide based. The paper also delves into the various applications of hybrid vectors. Because CPPs are able to carry cargo across the cellular membrane, they are a viable candidate for use as a suitable carrier for a wide variety of cargoes, such as siRNA, nanoparticles, and others. In which we discuss the CPPs, their classification, uptake mechanisms, hybrid vector systems, nanoparticles and their uptake mechanisms, etc. Further in this paper, we discuss CPPs conjugated to Nanoparticles, Combining CPPs with lipids and polymeric Nanoparticles in A Conjugated System, CPPs conjugated to nanoparticles for therapeutic purposes, and potential therapeutic uses of CPPs as delivery molecules. Also discussed the preclinical and clinical use of CPPS, intracellular trafficking of nanoparticles, and activatable and bioconjugated CPPs.

细胞穿透肽(CPPs)是一种分子,可提高细胞对不易穿过细胞膜的各种分子载荷的吸收。CPPs 可见于医药和医疗产品中。已发表的研究中讨论的绝大多数细胞穿透化学物质都是以肽为基础的。论文还深入探讨了混合载体的各种应用。由于 CPPs 能够携带货物穿过细胞膜,因此可以作为 siRNA、纳米颗粒等多种货物的合适载体。本文讨论了 CPPs、其分类、摄取机制、混合载体系统、纳米颗粒及其摄取机制等。此外,本文还讨论了与纳米颗粒共轭的 CPPs、在共轭体系中将 CPPs 与脂质和聚合物纳米颗粒结合、用于治疗目的的 CPPs 与纳米颗粒共轭以及 CPPs 作为递送分子的潜在治疗用途。此外,还讨论了 CPPS 的临床前和临床应用、纳米颗粒的细胞内转运以及可激活和生物共轭的 CPPs。
{"title":"Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways","authors":"Moataz Dowaidar","doi":"10.1016/j.mito.2024.101906","DOIUrl":"10.1016/j.mito.2024.101906","url":null,"abstract":"<div><p>Cell-penetrating peptides (CPPs) are molecules that improve the cellular uptake of various molecular payloads that do not easily traverse the cellular membrane. CPPs can be found in pharmaceutical and medical products. The vast majority of cell-penetrating chemicals that are discussed in published research are peptide based. The paper also delves into the various applications of hybrid vectors. Because CPPs are able to carry cargo across the cellular membrane, they are a viable candidate for use as a suitable carrier for a wide variety of cargoes, such as siRNA, nanoparticles, and others. In which we discuss the CPPs, their classification, uptake mechanisms, hybrid vector systems, nanoparticles and their uptake mechanisms, etc. Further in this paper, we discuss CPPs conjugated to Nanoparticles, Combining CPPs with lipids and polymeric Nanoparticles in A Conjugated System, CPPs conjugated to nanoparticles for therapeutic purposes, and potential therapeutic uses of CPPs as delivery molecules. Also discussed the preclinical and clinical use of CPPS, intracellular trafficking of nanoparticles, and activatable and bioconjugated CPPs.</p></div>","PeriodicalId":18606,"journal":{"name":"Mitochondrion","volume":"78 ","pages":"Article 101906"},"PeriodicalIF":4.4,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141140310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis 用贝扎贝特和烟酰胺核糖苷治疗 ACAD9 可暂时稳定心肌病和乳酸酸中毒的病情
IF 4.4 3区 生物学 Q2 CELL BIOLOGY Pub Date : 2024-05-24 DOI: 10.1016/j.mito.2024.101905
Johan L.K. Van Hove , Marisa W. Friederich , Daniella H. Hock , David A. Stroud , Nikeisha J. Caruana , Uwe Christians , Björn Schniedewind , Cole R. Michel , Richard Reisdorph , Edwin D.J. Lopez Gonzalez , Charles Brenner , Tonia E. Donovan , Jessica C. Lee , Kathryn C. Chatfield , Austin A. Larson , Peter R. Baker II , Shawn E. McCandless , Meghan F. Moore Burk

Pathogenic ACAD9 variants cause complex I deficiency. Patients presenting in infancy unresponsive to riboflavin have high mortality. A six-month-old infant presented with riboflavin unresponsive lactic acidosis and life-threatening cardiomyopathy. Treatment with high dose bezafibrate and nicotinamide riboside resulted in marked clinical improvement including reduced lactate and NT-pro-brain type natriuretic peptide levels, with stabilized echocardiographic measures. After a long stable period, the child succumbed from cardiac failure with infection at 10.5 months. Therapy was well tolerated. Peak bezafibrate levels exceeded its EC50. The clinical improvement with this treatment illustrates its potential, but weak PPAR agonist activity of bezafibrate limited its efficacy.

致病性 ACAD9 变异可导致复合体 I 缺乏症。对核黄素无反应的婴儿期患者死亡率很高。一名六个月大的婴儿出现核黄素无反应性乳酸酸中毒和危及生命的心肌病。使用大剂量贝扎贝特和烟酰胺核糖苷治疗后,临床症状明显改善,包括乳酸和NT-前脑型钠尿肽水平降低,超声心动图检查结果也趋于稳定。经过一段较长的稳定期后,患儿在 10 个半月时死于感染性心力衰竭。治疗效果良好。贝扎贝特的峰值水平超过了其 EC50。这种治疗方法的临床改善说明了它的潜力,但贝扎贝特较弱的PPAR激动剂活性限制了它的疗效。
{"title":"ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis","authors":"Johan L.K. Van Hove ,&nbsp;Marisa W. Friederich ,&nbsp;Daniella H. Hock ,&nbsp;David A. Stroud ,&nbsp;Nikeisha J. Caruana ,&nbsp;Uwe Christians ,&nbsp;Björn Schniedewind ,&nbsp;Cole R. Michel ,&nbsp;Richard Reisdorph ,&nbsp;Edwin D.J. Lopez Gonzalez ,&nbsp;Charles Brenner ,&nbsp;Tonia E. Donovan ,&nbsp;Jessica C. Lee ,&nbsp;Kathryn C. Chatfield ,&nbsp;Austin A. Larson ,&nbsp;Peter R. Baker II ,&nbsp;Shawn E. McCandless ,&nbsp;Meghan F. Moore Burk","doi":"10.1016/j.mito.2024.101905","DOIUrl":"10.1016/j.mito.2024.101905","url":null,"abstract":"<div><p>Pathogenic <em>ACAD9</em> variants cause complex I deficiency. Patients presenting in infancy unresponsive to riboflavin have high mortality. A six-month-old infant presented with riboflavin unresponsive lactic acidosis and life-threatening cardiomyopathy. Treatment with high dose bezafibrate and nicotinamide riboside resulted in marked clinical improvement including reduced lactate and NT-pro-brain type natriuretic peptide levels, with stabilized echocardiographic measures. After a long stable period, the child succumbed from cardiac failure with infection at 10.5 months. Therapy was well tolerated. Peak bezafibrate levels exceeded its EC<sub>50</sub>. The clinical improvement with this treatment illustrates its potential, but weak PPAR agonist activity of bezafibrate limited its efficacy.</p></div>","PeriodicalId":18606,"journal":{"name":"Mitochondrion","volume":"78 ","pages":"Article 101905"},"PeriodicalIF":4.4,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141140945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chelating mitochondrial iron and copper: Recipes, pitfalls and promise 螯合线粒体中的铁和铜:配方、陷阱和前景。
IF 4.4 3区 生物学 Q2 CELL BIOLOGY Pub Date : 2024-05-21 DOI: 10.1016/j.mito.2024.101903
Lucie J. Lamačová, Jan Trnka

Iron and copper chelation therapy plays a crucial role in treating conditions associated with metal overload, such as hemochromatosis or Wilson’s disease. However, conventional chelators face challenges in reaching the core of iron and copper metabolism – the mitochondria. Mitochondria-targeted chelators can specifically target and remove metal ions from mitochondria, showing promise in treating diseases linked to mitochondrial dysfunction, including neurodegenerative diseases and cancer. Additionally, they serve as specific mitochondrial metal sensors. However, designing these new molecules presents its own set of challenges. Depending on the chelator’s intended use to prevent or to promote redox cycling of the metals, the chelating moiety must possess different donor atoms and an optimal value of the electrode potential of the chelator–metal complex. Various targeting moieties can be employed for selective delivery into the mitochondria. This review also provides an overview of the current progress in the design of mitochondria-targeted chelators and their biological activity investigation.

铁和铜螯合疗法在治疗与金属超负荷有关的疾病(如血色沉着病或威尔逊氏病)方面发挥着至关重要的作用。然而,传统的螯合剂在进入铁和铜代谢的核心--线粒体时面临挑战。线粒体靶向螯合剂可以特异性地靶向清除线粒体中的金属离子,有望治疗与线粒体功能障碍有关的疾病,包括神经退行性疾病和癌症。此外,它们还是特异性线粒体金属传感器。然而,设计这些新分子也面临着一系列挑战。根据螯合剂防止或促进金属氧化还原循环的预期用途,螯合分子必须拥有不同的供体原子,以及螯合剂-金属复合物电极电位的最佳值。可采用各种靶向分子选择性地将药物输送到线粒体中。本综述还概述了线粒体靶向螯合剂设计及其生物活性研究的最新进展。
{"title":"Chelating mitochondrial iron and copper: Recipes, pitfalls and promise","authors":"Lucie J. Lamačová,&nbsp;Jan Trnka","doi":"10.1016/j.mito.2024.101903","DOIUrl":"10.1016/j.mito.2024.101903","url":null,"abstract":"<div><p>Iron and copper chelation therapy plays a crucial role in treating conditions associated with metal overload, such as hemochromatosis or Wilson’s disease. However, conventional chelators face challenges in reaching the core of iron and copper metabolism – the mitochondria. Mitochondria-targeted chelators can specifically target and remove metal ions from mitochondria, showing promise in treating diseases linked to mitochondrial dysfunction, including neurodegenerative diseases and cancer. Additionally, they serve as specific mitochondrial metal sensors. However, designing these new molecules presents its own set of challenges. Depending on the chelator’s intended use to prevent or to promote redox cycling of the metals, the chelating moiety must possess different donor atoms and an optimal value of the electrode potential of the chelator–metal complex. Various targeting moieties can be employed for selective delivery into the mitochondria. This review also provides an overview of the current progress in the design of mitochondria-targeted chelators and their biological activity investigation.</p></div>","PeriodicalId":18606,"journal":{"name":"Mitochondrion","volume":"78 ","pages":"Article 101903"},"PeriodicalIF":4.4,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The tissue-specific nature of physiological zebrafish mitochondrial bioenergetics 生理斑马鱼线粒体生物能的组织特异性。
IF 4.4 3区 生物学 Q2 CELL BIOLOGY Pub Date : 2024-05-21 DOI: 10.1016/j.mito.2024.101901
Rafael David Souto de Azevedo , Kivia Vanessa Gomes Falcão , Sinara Monica Vitalino de Almeida , Marlyete Chagas Araújo , Reginaldo Correia Silva-Filho , Maria Bernadete de Souza Maia , Ian Porto Gurgel do Amaral , Ana Catarina Rezende Leite , Ranilson de Souza Bezerra

Zebrafish are a powerful tool to study a myriad of experimental conditions, including mitochondrial bioenergetics. Considering that mitochondria are different in many aspects depending on the tissue evaluated, in the zebrafish model there is still a lack of this investigation. Especially for juvenile zebrafish. In the present study, we examined whether different tissues from zebrafish juveniles show mitochondrial density- and tissue-specificity comparing brain, liver, heart, and skeletal muscle (SM). The liver and brain complex IV showed the highest O2 consumption of all ETC in all tissues (10x when compared to other respiratory complexes). The liver showed a higher potential for ROS generation. In this way, the brain and liver showed more susceptibility to O2 generation when compared to other tissues. Regarding Ca2+ transport, the brain showed greater capacity for Ca2+ uptake and the liver presented low Ca2+ uptake capacity. The liver and brain were more susceptible to producing NO. The enzymes SOD and Catalase showed high activity in the brain, whereas GPx showed higher activity in the liver and CS in the SM. TEM reveals, as expected, a physiological diverse mitochondrial morphology. The essential differences between zebrafish tissues investigated probably reflect how the mitochondria play a diverse role in systemic homeostasis. This feature may not be limited to normal metabolic functions but also to stress conditions. In summary, mitochondrial bioenergetics in zebrafish juvenile permeabilized tissues showed a tissue-specificity and a useful tool to investigate conditions of redox system imbalance, mainly in the liver and brain.

斑马鱼是研究各种实验条件(包括线粒体生物能)的有力工具。考虑到线粒体因所评估的组织不同而在许多方面存在差异,在斑马鱼模型中仍然缺乏这方面的研究。尤其是幼年斑马鱼。在本研究中,我们对斑马鱼幼鱼的不同组织是否表现出线粒体密度和组织特异性进行了比较,包括大脑、肝脏、心脏和骨骼肌(SM)。在所有组织的所有 ETC 中,肝脏和大脑复合体 IV 的氧气消耗量最高(是其他呼吸复合体的 10 倍)。肝脏产生 ROS 的潜力更高。因此,与其他组织相比,大脑和肝脏更容易产生 O2-。在 Ca2+ 运输方面,大脑摄取 Ca2+ 的能力较强,而肝脏摄取 Ca2+ 的能力较弱。肝脏和大脑更容易产生 NO。脑中的 SOD 和过氧化氢酶活性较高,而肝中的 GPx 和 SM 中的 CS 活性较高。正如预期的那样,TEM 揭示了线粒体形态的生理多样性。所研究的斑马鱼组织之间的本质区别可能反映了线粒体在系统平衡中发挥的不同作用。这一特征可能不仅限于正常的代谢功能,还包括应激条件。总之,斑马鱼幼鱼通透组织线粒体生物能显示出组织特异性,是研究氧化还原系统失衡状况(主要是肝脏和大脑)的有用工具。
{"title":"The tissue-specific nature of physiological zebrafish mitochondrial bioenergetics","authors":"Rafael David Souto de Azevedo ,&nbsp;Kivia Vanessa Gomes Falcão ,&nbsp;Sinara Monica Vitalino de Almeida ,&nbsp;Marlyete Chagas Araújo ,&nbsp;Reginaldo Correia Silva-Filho ,&nbsp;Maria Bernadete de Souza Maia ,&nbsp;Ian Porto Gurgel do Amaral ,&nbsp;Ana Catarina Rezende Leite ,&nbsp;Ranilson de Souza Bezerra","doi":"10.1016/j.mito.2024.101901","DOIUrl":"10.1016/j.mito.2024.101901","url":null,"abstract":"<div><p>Zebrafish are a powerful tool to study a myriad of experimental conditions, including mitochondrial bioenergetics. Considering that mitochondria are different in many aspects depending on the tissue evaluated, in the zebrafish model there is still a lack of this investigation. Especially for juvenile zebrafish. In the present study, we examined whether different tissues from zebrafish juveniles show mitochondrial density- and tissue-specificity comparing brain, liver, heart, and skeletal muscle (SM). The liver and brain complex IV showed the highest O<sub>2</sub> consumption of all ETC in all tissues (10x when compared to other respiratory complexes). The liver showed a higher potential for ROS generation. In this way, the brain and liver showed more susceptibility to O<sub>2</sub><sup><img>−</sup> generation when compared to other tissues. Regarding Ca<sup>2+</sup> transport, the brain showed greater capacity for Ca<sup>2+</sup> uptake and the liver presented low Ca<sup>2+</sup> uptake capacity. The liver and brain were more susceptible to producing <sup><img></sup>NO. The enzymes SOD and Catalase showed high activity in the brain, whereas GPx showed higher activity in the liver and CS in the SM. TEM reveals, as expected, a physiological diverse mitochondrial morphology. The essential differences between zebrafish tissues investigated probably reflect how the mitochondria play a diverse role in systemic homeostasis. This feature may not be limited to normal metabolic functions but also to stress conditions. In summary, mitochondrial bioenergetics in zebrafish juvenile permeabilized tissues showed a tissue-specificity and a useful tool to investigate conditions of redox system imbalance, mainly in the liver and brain.</p></div>","PeriodicalId":18606,"journal":{"name":"Mitochondrion","volume":"77 ","pages":"Article 101901"},"PeriodicalIF":4.4,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mitochondrion
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1